Therapeutic Effects of Aripiprazole in the 5xFAD Alzheimer’s Disease Mouse Model

Global aging has led to growing health concerns posed by Alzheimer’s disease (AD), the most common type of dementia. Aripiprazole is an atypical FDA-approved anti-psychotic drug with potential against AD. To investigate its therapeutic effects on AD pathology, we administered aripiprazole to 5xFAD A...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Ye Ji, Son, Yeonghoon, Park, Hye-Jin, Oh, Se Jong, Choi, Jae Yong, Ko, Young-Gyu, Lee, Hae-June
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431331/
https://www.ncbi.nlm.nih.gov/pubmed/34502282
http://dx.doi.org/10.3390/ijms22179374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431331/
https://www.ncbi.nlm.nih.gov/pubmed/34502282
http://dx.doi.org/10.3390/ijms22179374

Ejemplares similares